Objective
Plant-derived pharmaceuticals (PDPs) have immense potential to address the economic and capacity limitations of current fermenter-based production technology. Several complex multi-subunit and glycosylated proteins have been produced in transgenic plants, which are safe, convenient and cost-effective for large-scale production. High-biomass leaf and seed crops, such as maize and tobacco, are the most widely used. However, since most clinically-relevant recombinant proteins are glycosylated, one hurdle to the widespread commercial production of therapeutic proteins in plants is the fact that plant N-glycans differ from those found in humans, potentially limiting the therapeutic potential of PDPs. Glyco-engineering, to make plants that generate recombinant glycoproteins with human-like N-glycans is therefore an import goal. Most plant-derived glycoproteins studied thus far have a mix of N-glycans whose profile differs according to species, organ and physiological state. In maize seeds, we have shown that the N-glycans on a recombinant antibody were trimmed extensively, indicating the presence of ENGase activity in the endomembrane system of maize endosperm. In order to realize the greatest benefit from maize as a production system, it is important to characterize this enzymatic activity and the corresponding gene. We propose to utilize transgenic maize lines expressing two marker glycoproteins to monitor ENGase activity and subcellular localization in order to isolate, characterize and clone the ENGase gene. This will help in the development of a maize production system for improved glycoprotein therapeutics with appropriate glycans.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs
- natural sciences biological sciences biochemistry biomolecules proteins
- natural sciences biological sciences biochemistry biomolecules carbohydrates
- agricultural sciences agriculture, forestry, and fisheries agriculture grains and oilseeds cereals
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-2007-4-3-IRG
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
1180 Wien
Austria
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.